Want to join the conversation?
$C 2Q15 Call: In terms of the impact of GSIB surcharges on Citigroup’s return profile and payout capacity, John said it would impact the entire industry, not just the company. He added that it will depend upon what GSIB surcharge it were to add to CCAR requirements.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?